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catalase and glutathione peroxidase protection
are associated with aging sarcopenia
Melanie J Sullivan-Gunn1 and Paul A Lewandowski2*Abstract
Background: Sarcopenia is the progressive loss of skeletal muscle that contributes to the decline in physical
function during aging. A higher level of oxidative stress has been implicated in aging sarcopenia. The current study
aims to determine if the higher level of oxidative stress is a result of increased superoxide (O2‾ ) production by the
NADPH oxidase (NOX) enzyme or decrease in endogenous antioxidant enzyme protection.
Methods: Female Balb/c mice were assigned to 4 age groups; 6, 12, 18 and 24 months. Body weight and animal
survival rates were recorded over the course of the study. Skeletal muscle tissues were collected and used to
measure NOX subunit mRNA, O2‾ levels and antioxidant enzymes.
Results: Key subunit components of NOX expression were elevated in skeletal muscle at 18 months, when
sarcopenia was first evident. Increased superoxide dismutase 1 (SOD1) activity suggests an increase in O2‾
dismutation and this was further supported by elevated levels of hydrogen peroxide (H2O2) and decline in catalase
and glutathione peroxidase (GPx) antioxidant protection in skeletal muscle at this time. NOX expression was also
higher in skeletal muscle at 24 months, however this was coupled with elevated levels of O2‾ and a decline in
SOD1 activity, compared to 6 and 12 months but was not associated with further loss of muscle mass.
Conclusions: While the source of ROS in sarcopenic muscle remains unknown, this study provides evidence that
the NOX enzyme could be involved in ROS production by regulating superoxide in ageing muscles. This study also
suggests that H2O2 is the key ROS in the onset of sarcopenia and that the decline in antioxidant protection by
catalase and GPx is indicative of antioxidant dysfunction and may therefore be a major contributing factor in the
development or onset of sarcopenia. Furthermore, the changes in ROS and antioxidant activity after sarcopenia was
first evident gives some evidence for a compensatory mechanism, in response to insult, in order to maintain
muscle integrity.
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One of the most dramatic phenotypic changes during
aging is sarcopenia [1,2]. Sarcopenia is characterised by
a significant loss of skeletal muscle mass [3] at a rate of 5%
per decade, starting in the fourth decade [4] with a preva-
lence of 5-13% in people 60-70 years of age and 11-50%
of people over 80 years [5]. Consequently, the progressive
age-associated loss of muscle mass leads to significant
weakness, frailty and decreased quality of life [6]. It has* Correspondence: paul.lewandowski@deakin.edu.au
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use, distribution, and reproduction in any medrecently been reported that sarcopenia causes significant
frailty in the elderly that any stressor leads to a poor out-
come, disability and mortality [5] despite age, clinical and
functional variability [7].
The free radical theory of aging postulates that en-
dogenous reactive oxygen species (ROS) cause progres-
sive cellular damage and that incomplete repair leads to
an accumulation over time [8]. ROS are generated in
skeletal muscle as by-products of cellular metabolism,
but are capable of exceeding beyond normal cellular
levels, during exercise [1] and in disease [9-11] and thesee BioMed Central Ltd. This is an open access article distributed under the
icense (http://creativecommons.org/licenses/by/2.0), which permits unrestricted
ium, provided the original work is properly cited.
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cient over time [12].
The knowledge that the NADPH oxidase (NOX) en-
zyme is a primary superoxide (O2‾) producing system
[13] has brought about much speculation for its role in
skeletal muscle. The NOX catalytic subunit NOX2 [9],
associated subunit components, p22phox, p40phox, p47phox
and p67phox [14], GTP binding protein Rac1 [15] and the
NOX2 homologue NOX4, have been found in skeletal
muscle tissue [16]. Although limited research exists,
aging studies have demonstrated an age-associated in-
crease in ROS as a consequence of NOX2 enzyme up
regulation [11] and activity [17], and decreases in endo-
thelial dysfunction and vascular aging have been reported
in NOX2 deficient mice [18,19]. Overexpression of NOX4
has been proposed to lead to cellular senescence in fibro-
blasts [20] and degenerative dysfunction associated with
aging [21]. Furthermore, NOX has been identified as the
key source of O2‾ that contributes to cardiovascular aging
[11] and other age-associated conditions such as diabetes
[22], arthritis [23], cataracts [24], Alzheimer’s disease [25]
and motorneuron dysfunction [10].
The high metabolic activity of skeletal muscle makes it
particularly vulnerable to excess ROS production and
oxidative stress [26]. Antioxidant enzymes are therefore
important in skeletal muscle and contrasting studies
have propose both a compensatory increase in antioxi-
dant activity [27] as well as evidence to suggest antioxi-
dant dysfunction [12] during aging. Superoxide dismutase
(SOD) is responsible for the dismutation of O2‾ and elim-
ination of cellular oxidative stress. The absence of the
cytosolic SOD1 isoform is known to significantly decrease
lifespan [28] and more recently, high levels of oxidative
stress and accelerated sarcopenia due to O2‾ induced
neuromuscular degeneration and mitochondrial dysfunc-
tion has been shown in SOD1 deficient mice [29-31].
Oxidative stress is recognised as a major contributor
to aging and age-associated disease [10,29,32] and evi-
dence suggests its involvement in the development of
sarcopenia [1]. However, the key contributors to oxida-
tive stress in skeletal muscle during aging and changes
within these systems throughout the lifespan, remains
undefined. Therefore, this study aims to investigate the
NOX and antioxidant enzyme systems in aging skeletal
muscle. In particular, this study aims to determine
changes in the NOX proteins; NOX2, NOX4, p22phox,
p40phox, p47phox, p67phox and Rac1, O2‾ and H2O2 levels
and associated antioxidants; SOD isoforms, catalase and
GPx, in skeletal muscle during aging.
Methods
Animal model of aging sarcopenia
All animal procedures carried out in this study were ap-
proved by the Victoria University Animal Ethics Committee(AEETH 14/05). Female Balb/c mice were assigned to 4 age
groups; 6, 12, 18 and 24 months of age and maintained
under controlled environmental conditions; 12 hour light/
dark cycle, 21 ± 2C, 30% humidity, in conventional cages
with ad libitum access to standard chow and water. Body
weight measurements and animal survival rates were
recorded over the course of the study. Skeletal muscle tis-
sues were collected from 6 (n = 16), 12 (n = 18), 18 (n = 12)
and 24 (n = 12) month old mice and immediately snap fro-
zen in liquid nitrogen and stored at -80°C for later use.
Detection of O2‾ by DHE fluorescence staining
Skeletal muscle O2‾ was measured by histological
Dihydroethidium (DHE) fluorescence examination. DHE
is cell permeable and reacts with O2‾ converting DHE
into ethidium fluorescence [33]. DHE (5 μm/L) was ap-
plied to quadriceps cryosections (5 μm) and incubated
in a light protected oven at 37°C for 30 minutes. The
DHE was washed from the sections with PBS and fluor-
escence was assessed using Axiocam HBO 50/AC fluor-
escence microscopy (Zeiss, Germany). The intensity of
ethidium fluorescence detection of O2‾ was measured
with MCID imaging software (Imaging Research Inc.
Australia) with excitation at 480 nm and emission at
560 nm. Values represent the area of fluorescence, above
a specified threshold, expressed as a percentage of the
total area of the muscle cross-section [34].
Reverse transcription-real-time PCR
RNA was extracted from frozen quadriceps muscle using
Tri Reagent (Molecular Research Centre, USA), according
to the manufacturer’s protocol. Total RNA concentration
was determined spectrophotometrically at 260 nm. First-
strand cDNA was generated from 1 μg RNA using AMV
RT (Promega, Australia). Pre-designed TaqMan Gene
Expression Assays (Applied Biosystems, USA) were used
containing specific primers and probes for the gene of
interest. Real-time PCR was performed using Applied
Biosystems 7500 detection system following manufac-
turer’s instructions (Applied Biosystems, USA) and PCR
reactions were performed using TaqMan Gene Expression
Master Mix (Applied Biosystems, USA). To compensate
for variations in input RNA amounts and efficiency of re-
verse transcription, 18 s ribosomal mRNA was quantified
and all results were normalised to these values. Fluores-
cent emission data was captured and mRNA levels were
analysed using the critical threshold value (CT) [35].
Protein electrophoresis and western blotting
Protein was extracted from frozen quadriceps muscle ho-
mogenized in ice-cold radio- immunoprecipitation assay
(RIPA) buffer containing Tris HCl (50 mmol/L; pH 7.4),
NaCl (150 mmol/L), NP-40 (1%), sodium deoxycholate
(0.5%) and SDS (0.1%) and centrifuged at 13,000 × g for
18mo 24mo
Figure 1 Animal survival rates in the 18 and 24 month old age
groups, expressed as a percentage of live animals for each
group. Female BALB/c mice purchased at 9 months of age were
assigned to the 18 month old group (n = 20) and 24 month old
group (n = 24). Animal survival declined from approximately
14 months of age in both groups and continued to decline
thereafter. A 60% decline in animal survival was observed in the
18 month old group (18 m/o), while a 50% decline in survival rate
was observed the 24 month old group (24 m/o).
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protein concentration was determined by the Bradford
method (Bio-Rad) and equal amounts of protein were sep-
arated by SDS-PAGE and transferred to polyvinylidene
difluoride membranes. The membranes were blocked for
2 hours at room temperature in Tris-buffered saline
containing Tris-HCl (20 mM; pH 7.6) NaCl (137 mM)
and Tween 20 (0.1%) with 5% BSA and probed with pri-
mary antibodies for either NOX2 (gp91phox), p40phox,
p67phox or GAPDH (1:200; SantaCruz Biotechnology)
overnight at 4°C. Antibody binding was detected using
horseradish peroxidase conjugated secondary antibody
(1:50,000; SantaCruz Biotechnology). The protein bands
were detected by SuperSignal West Dura chemilumines-
cence reagents (Thermo Scientific). The LAS 4000
Imaging System (Fujifilm Life Science, USA) was used to
visualize protein bands and densitometry was performed
with MultiGauge software (Fujifilm Life Science, USA).
To compensate for variation in protein loading the relative
density of immunoreactive bands were normalized to the
density of the corresponding bands for GAPDH.
Antioxidant enzyme activity and hydrogen peroxide
assays
Spectrophotometric assay kits were used to measure
SOD (Cayman-706002), catalase (Cayman-707002) and
GPx (Cayman-703102) activity and H2O2 (Cayman-
600050) levels, in muscle homogenates. Frozen muscle
pieces (100 mg) were placed in ice-cold HEPES buffer
(20 mM) containing EGTA (1 mM), mannitol (210 mM)
and sucrose (70 mM) and adjusted to a pH of 7.2
(10 ml/g). Muscle aliquots were homogenised in buffer,
using a glass on glass homogeniser, and centrifuged at
1,500 × g for 5 min at 4°C to remove insoluble connect-
ive tissue. For the detection of SOD1 and SOD2, cyto-
solic and mitochondrial fractions were separated. The
supernatant was centrifuged at 10,000 × g for 5 min at 4°C,
and the resulting supernatant, containing the cytosolic
fraction, was collected for SOD1 enzyme analysis. The
remaining pellet containing the mitochondrial fraction
was resuspended and homogenised in ice cold HEPES
buffer (20 mM) for SOD2 enzyme analysis. SOD1 and
SOD2 activity was measured in cytosolic and mito-
chondrial muscle fractions, respectively. The amount
of enzyme activity and H2O2 levels were calculated and
standardised for protein using the Bradford method
(Bio-Rad).
Statistical analysis
Statistical analysis was performed using SPSS statistical
package (version 15.0). Results were expressed as mean ±
SEM. Differences were determined by one-way ANOVA
with Tukey HSD as posthoc and results were considered
statistically significant if p values ≤0.05.Results
Establishment of murine model of aging sarcopenia
Survival rates of female Balb/c mice began to decline at
approximately 14 months of age with a 60% survival rate
in the 18 month group and a 50% survival rate in the
24 month group (Figure 1). Skeletal muscle mass and
muscle mass as ratio to body weight increased at
12 months of age compared to 6 months of age (p < 0.001,
Table 1) and decreased at 18 (p < 0.001) and 24 (p < 0.001)
months of age compared to 12 months (Table 1).
O2‾ Levels in skeletal muscle of aging mice
Ethidium fluorescence was elevated throughout the quad-
riceps muscle from 24 month old mice compared to
6 (p = 0.001) and 12 (p < 0.001) month old mice (Figure 2).
Similar levels of fluorescence were observed between the
other age groups (Figure 2).
MRNA expression of Pro-oxidant and antioxidant
enzymes in skeletal muscle of aging mice
The mRNA expression of the NOX enzyme subunits
showed differential expression in skeletal muscle during
aging. The catalytic NOX2 subunit was higher in the
quadriceps muscle at 18 months compared to the youn-
ger 6 (p = 0.027) and 12 (p = 0.023) month old mice to-
gether with the older 24 (p = 0.047) month old mice
(Table 2). Similarly, the mRNA expression of the NOX2
regulatory subunit, p40phox was higher in the quadriceps
muscle at 18 months compared to the younger 6 month
old mice (p = 0.030, Table 2). Interestingly, the mRNA
expression of the catalytic NOX2 type subunit p67phox
Table 1 Body weight and quadriceps muscle weights
Age (months)
6 (n = 16) 12 (n = 18) 18 (n = 12) 24 (n = 12)
Body weight (g) 30 ± 1.8 27 ± 2.2 28 ± 1.3 28 ± 1.3
Quadriceps weight (g) 0.15 ± 0.02 0.18 ± 0.01acd 0.15 ± 0.02 0.16 ± 0.01
Body weight/quadriceps weight ratio 5.08 ± 0.59 6.15 ± 1.72acd 5.45 ± 0.38 5.55 ± 0.52
The values represent the mean ± SEM.
Statistically significant differences (P < 0.05) between groups are indicated by lower case letters, where a6 m/o, c18 m/o and d24 m/o.
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pared to the younger 6 (p = 0.007), 12 (p = 0.001) and 18
(p = 0.032) month old mice (Table 2). The mRNA ex-
pression of the NOX2 subunits, p22phox and p47phox and
NOX2 subunit regulator, Rac1 were similar in the
quadriceps muscle from all age groups. Like the NOX2
subunit itself, the mRNA expression of the catalytic
NOX2 homologue, NOX4 was higher in the quadriceps
muscle at 18 months compared to 6 months (p = 0.021,
Table 2).D
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Figure 2 O2‾ levels in aging skeletal muscle, by histological DHE exam
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0.005, p = 0.016), 12 (p = 0.010, p = 0.006) and 18 (p =
0.043, p = 0.012) month old mice (Table 2). Similarly, the
mRNA expression of the antioxidant enzyme GPx was
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to the younger 6 month old mice (p = 0.031, Table 2).(months)
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Table 2 Relative gene expression in aging skeletal muscle
Age (months)
6 (n = 16) 12 (n = 18) 18 (n = 12) 24 (n = 12)
Gene
expression (AU)
NOX2 13.1 ± 2.9 11.0 ± 3.1 110 ± 14.7abd 23.0 ± 4.4
p22phox 17.8 ± 3.7 26.5 ±7.0 25.1 ± 9.4 48.7 ± 10.3
p40phox 14.0 ± 4.9 25.2 ± 8.7 57.7 ± 16.9a 42.9 ± 8.9
p47phox 3.1 ± 0.6 4.8 ± 1.4 16.4 ± 7.9 4.2 ± 1.2
p67phox 72.9 ± 13.4 41.1 ± 8.9 103 ± 33.0 272 ± 71abc
NOX4 1.5 ± 0.3 4.3 ± 1.0 9.2 ± 3.2a 5.1 ± 1.3
Rac1 1.2 ± 1.1 3.91 ± 0.9 2.9 ± 1.3 5.3 ± 0.8
SOD1 16.1 ± 5.2 19.3 ± 5.1 33.6 ± 11.0 69.6 ± 15.6abc
SOD2 7.9 ± 2.1 6.6 ± 1.5 6.7 ± 2.6 19.5 ± 4.0abc
SOD3 1.7 ± 0.4 1.51 ± 0.2 2.5 ± 1.3 2.9 ± 0.8
Gpx 16.5 ± 4.3 42.2 ± 10.2 56.4 ± 22.7 40.5 ± 6.0a
Catalase 19.4 ± 5.1 28.1 ± 8.1 34.4 ± 10.3 52.0 ± 9.0
The values represent the mean ± SEM, with all results normalised to 18 s
ribosomal mRNA. Statistically significant differences (P < 0.05) between groups
are indicated by lower case letters, where a6 m/o, b12 m/o, c18 m/o
and d24 m/o.
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extracellular SOD3 antioxidant enzyme and catalase in
the quadriceps muscle from all age groups (Table 2).
Protein levels of NOX2 enzyme subunits in skeletal
muscle of aging mice
Changes in the mRNA levels of the key NOX2 enzyme
subunits; NOX2, p40phox and p67phox lead to further
analysis of protein expression. The protein expression of
the regulatory NOX2 enzyme subunit p40phox was lower
in the quadriceps muscle at 24 months compared to the
younger 6 (p = 0.039) and 18 (p = 0.001) month old mice
(Figure 3). However, the protein expression of the cata-
lytic NOX2 enzyme subunit p67phox was higher in the
quadriceps muscle at 24 months compared to the younger
6 (p = 0.027) and 18 (p = 0.004) month old mice (Figure 3)
and NOX2 protein expression was similar in all age groups
(Figure 3).
Antioxidant enzyme activity and hydrogen peroxide
levels in skeletal muscle of aging mice
The changes in SOD mRNA expression lead to the in-
vestigation of SOD enzyme activity in skeletal muscle dur-
ing aging. SOD1 activity levels were elevated in the
quadriceps muscle at 18 months compared to the younger
6 (p < 0.001), 12 (p < 0.001) and older 24 (p = 0.011) month
old mice (Table 3), and SOD1 activity in the quadriceps
muscle at 12 months compared to 6 (p = 0.005), 18 (p <
0.001) and 24 (p < 0.001) months (Table 3). Additionally,
SOD2 activity levels were lower in the quadriceps muscleat 24 months compared to the younger 6 (p < 0.001) and
12 (p < 0.001) month old mice (Table 3).
Changes in SOD antioxidant activity for the
dismutation of O2‾ to H2O2 lead to further investigation
of the H2O2 specific antioxidant enzymes, GPx and cata-
lase. GPx activity levels were lower in skeletal muscle at
18 months compared to the younger 6 (p = 0.001), 12
(p < 0.001) and older 24 (p = 0.004) month old mice
(Table 3). Similarly, catalase activity levels were lower
in the quadriceps muscle at 18 months compared to
the younger 12 (p < 0.001) and older 24 (p = 0.004)
month old mice, and higher at 12 months compared
to 6 months (p = 0.043) (Table 3).
Elevated levels of O2‾ and increased SOD activity lead
to further investigations of H2O2 levels in skeletal
muscle during aging. H2O2 were elevated in the quadri-
ceps muscle at 18 months compared to the younger 6
(p < 0.001), 12 (p < 0.001) and older 24 (p = 0.002) month
old mice (Table 3).
Discussion
Sarcopenia has been described as a multifactorial syn-
drome developing from changes in muscle morphology,
oxidative stress, inflammation, physical activity and nu-
trition [36]. The accumulation of ROS and evidence of
oxidised proteins has been implicated in sarcopenic
muscle, however the attenuation and suppression of this
disease remains contradictory. The present study dem-
onstrates a loss of skeletal muscle mass at 18 months
that is indicative of sarcopenia. This sarcopenic muscle
had elevated levels of H2O2 and low levels of the antioxi-
dant enzymes, catalase and GPx. While the source of
ROS in sarcopenic muscle remains relatively unknown,
this study gives evidence for the NOX2 enzyme with an
increase in the expression of the essential subunit com-
ponents. This study also suggests a compensatory re-
sponse to muscle insult with elevated levels of O2‾ and a
decline in SOD1 protection and no further loss of
muscle mass at 24 months.
The present study supports others who have demon-
strated significant loss of skeletal muscle mass and cellu-
lar changes during aging [3,27,37]. Pansarasa et al.
(1999) proposed that in humans, 65 years of age is the
time of most significant change and associated damage
in muscle [27]. Kimball et al. (2004) demonstrated age
related decline in skeletal muscle mass at 18 months of
age in mice and evidence of sarcopenia from 21-27
months of age [3]. Aging in general is associated with an
increase in oxidative stress and steady rise over the life-
span [38]. Pansarasa et al. (1999) suggested a correlation
between ROS activity and age related changes in human
skeletal muscle [27], while a similar study by Mecocci et al.
(1999) demonstrated age related oxidative damage
and significant loss of muscle mass [39]. Studies to date,
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Figure 3 The protein levels of the NOX2 enzyme subunits and protein levels in aging skeletal muscle. A. Representative blots for NOX2,
p40phox, p67phox and GAPDH. B. Graphical representation of protein concentration expressed as arbitrary units (AU) after normalisation for GAPDH
concentration. The values represent the mean ± SEM. Statistically significant differences (P < 0.05) between groups are indicated by lower case
letters, where a = 6 m/o, b = 12 m/o, c = 18 m/o and d = 24 m/o.
Sullivan-Gunn and Lewandowski BMC Geriatrics 2013, 13:104 Page 6 of 9
http://www.biomedcentral.com/1471-2318/13/104
Table 3 Enzyme activity and hydrogen peroxide levels in aging skeletal muscle
Age (months)
6 (n = 16) 12 (n = 18) 18 (n = 12) 24 (n = 12)
SOD1 (U/mg protein) 19.4 ± 1.3 9.1 ± 0.3acd 30.8 ± 2.5abd 25.9 ± 1.3
SOD2 (U/mg protein) 5.7 ± 0.5 5.7 ± 0.4 4.7 ± 0.3 3.4 ± 0.1ab
GPx (U/mg protein) 1.0 ± 0.2 1.1 ± 0.1a 0.7 ± 0.1abd 0.9 ± 0.2
Catalase (U/mg protein) 9.3 ± 0.9 12.1 ± 1.2a 8.8 ± 1.2bd 10.2 ± 0.9
Hydrogen Peroxide (μM) 1.12 ± 0.07 1.16 ± 0.04 2.42 ± 0.05abd 1.74 ± 0.06
Superoxide (AFU) 8.1 ± 1.3 8.0 ± 0.3 8.9 ± 1.1 10.0 ± 0.6ab
The values represent the mean ± SEM.
Statistically significant differences (P < 0.05) between groups are indicated by lower case letters, where a6 m/o, b12 m/o, c18 m/o and d24 m/o.
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old animals for muscle comparison [29,39-41], whereas
the present study investigated aging skeletal muscle with
four age groups that represent the progressive aging
process and development of sarcopenia.
The significant decline in skeletal muscle mass found
at 18 months was matched by a marked increase in the
mRNA expression of NOX2 and p40phox, compared to 6
and 12 months. These two subunits are absolutely ne-
cessary for the regulation, assembly and activation of the
NOX2 enzyme and generation of O2‾ [42]. The increase
in NOX was not matched by an increase in O2‾, how-
ever further investigation in SOD1 activity suggests a
well regulated antioxidant system in skeletal muscle at
this time. The increase in O2‾ dismutation would indeed
increase H2O2 levels in the cell and require antioxidant
protection from catalase and GPx. However, despite the
increase in H2O2 in skeletal muscle at 18 months com-
pared to all other age groups, catalase and GPx appear
to be unresponsive to the consequential increase in
H2O2. The present study therefore gives evidence for
antioxidant dysfunction during aging and at the onset of
sarcopenia.
Increased levels of H2O2 have been found in aging
skeletal muscle. Capel et al. (2004) demonstrated an in-
crease in mitochondrial H2O2 release in the tibialis an-
terior (TA) muscles of 24 month old male Wister rats
with sarcopenia when compared to 4.5 months [43], and
this was later confirmed in the vastis lateralis muscle of
elderly subjects [44]. Jackson et al. (2011) also demon-
strated an increase in H2O2 levels in the gastrocnemius
muscle of 18 and 24 month old mice when compared to
the younger 6 months [45]. While Siu et al. (2008) found
a similar increase in H2O2 levels in the gastrocnemius
muscle of aged rats with significant loss of muscle mass,
despite increased catalase activity [46]. Like these studies
the present study supports H2O2 as a significant con-
tributor in the development of sarcopenia.
A potential mechanism for H2O2, generated by NOX,
in the development of sarcopenia has been proposed.
Sriram et al. (2011) recently reported a feed forwardloop of Myostatin (Mstn) induced TNF-α and NOX gen-
erated H2O2 as a second messenger where TNF-α in
turn increases the expression of Mstn via transcrip-
tion factor nuclear factor kappa beta (NF-κβ) [47].
Mstn is a known negative regulator of muscle growth.
Overexpression of Mstn reduces muscle mass while Mstn
deficiency has shown a 2 fold increase in muscle mass
compared to wild types [48]. A recent study by McKay
et al. (2012) demonstrated a 2 fold increase in myostatin
mRNA levels in old muscle and suggests that myostatin
impairs myogenic capacity in aged muscle [49]. In
addition to the role of Mstn in sarcopenia, muscle wasting
in sarcopenic rat muscle has been associated with in-
creased Ubiquitin Proteasome System (UPS) activity [50].
Clavel et al. (2006) also reported increased UPS activity
and expression of the atrophy related MuRF-1 and
atrogin-1 genes in aged rat muscle that is suggested to be
induced by TNF-α [51]. Furthermore, H2O2 has been
shown to stimulate the UPS and expression of MuRF-1
and atrogin-1 in skeletal muscle myotubes [52]. Taken to-
gether, it is possible that NOX generated H2O2 acts as a
second messenger for Mstn induced TNF-α and down-
stream regulation of the UPS in aging skeletal muscle
sarcopenia.
However, H2O2 levels were not elevated in the quadri-
ceps muscle at 24 months and there was no further loss
of muscle mass. Instead, O2‾ levels were elevated in this
muscle together with a decline in SOD1 activity. While
this would suggest antioxidant dysfunction it is entirely
possible that it is a regulated response to decrease H2O2
production and reduce further muscle wasting. Previous
studies have demonstrated a compensatory mechanism
in skeletal muscle that may occur in response to insult
and the onset of muscle wasting. Edstrom et al. (2006)
recently demonstrated a significant downregulation in
atrophy related genes in sarcopenic skeletal muscle from
30 month old rats when compared to 4 and 12 months
[53]. The potential decrease in muscle atrophy at 30 months
could have been a compensatory response to earlier muscle
loss that this particular study did not investigate. In further
support of this, Kimball et al. (2004) found that while
Sullivan-Gunn and Lewandowski BMC Geriatrics 2013, 13:104 Page 8 of 9
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markers of protein synthesis were elevated at 24 and
27 months of age [3]. A more recent study by Zhang et al.
(2013), reported muscle weakness but no atrophy in
18 month old SOD1 deficient mice suggesting that SOD1
may be involved in muscle regenerative pathways [54]. In-
vestigation into these complex systems in skeletal muscle
would help to better understand the mechanisms involved
in the development of sarcopenia.
The present study supports NOX2 enzyme involve-
ment in the development of sarcopenia. The increase in
the catalytic NOX2 enzyme subunit p67phox in skeletal
muscle at 24 months suggests that the source of O2‾
may be NOX2 generated. Like NOX2, NOX4 mRNA
levels were also elevated in skeletal muscle at 18 months.
In contrast to NOX2, NOX4 requires only p22phox for
oxidase activation and generation of O2‾ [9,55] and does
not appear to reside in the plasma membrane, rather its
localization is within intracellular organelles and gener-
ates O2‾ intracellularly [56,57]. However, the localisation
of NOX4 in skeletal muscle is yet to be defined and
therefore its role in skeletal muscle aging remains un-
known. It is also important to note that because the
NOX4 enzyme potentially generates O2‾ within subcel-
lular compartments, such as the endoplasmic reticulum,
it is undetectable by DHE [20,58]. Indeed, an increase in
NOX4-generated O2‾ production in intracellular organ-
elles has the potential to cause considerable damage to
cellular structures and has been suggested to contribute
to cellular senescence [20]. The results from this study
indicate the potential for NOX4 as a subcellular regula-
tor of O2‾ and suggests further investigation into its
localization and thereby its role in skeletal muscle and
sarcopenia.
Conclusions
This study investigated oxidative systems in the develop-
ment of sarcopenia in an otherwise healthy mouse
model of aging. The time of significant change in skeletal
muscle was at 18 months with an increase in NOX2 en-
zyme expression and levels of H2O2, antioxidant dysfunc-
tion and the onset of sarcopenia. However, while NOX2
enzyme expression was also increased in skeletal muscle
at 24 months, O2‾ levels were elevated with SOD1 antioxi-
dant dysfunction and maintenance of muscle mass. This
study indeed supports oxidative changes in muscle during
aging that may be both inductive of sarcopenia and a com-
pensatory mechanism to maintain muscle integrity. This
study suggests that elevated levels of H2O2 from NOX2 at
18 months, is a key component in the onset of sarcopenia.
In contrast, the increase in O2‾ and decline in SOD1
activity at 24 months may be a regulated response to
decrease H2O2 levels and further muscle insult. Fur-
thermore, while this study suggests that H2O2 is thekey oxidant in the onset of sarcopenia, the lack of antioxi-
dant protection from catalase and GPx is equally as im-
portant, whereas the lack of SOD1 antioxidant protection
at 24 months does not appear to contribute to sarcopenia.
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